J. Graham Beaumont
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
J. Graham Beaumont has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
Pamela M. Kenealy
Royal Hospital for Neuro-disability, London and School of Human and Life Sciences, Roehampton University
2 shared publicationsA. MacLehose
The Institute for Neuropalliative Rehabilitation, Royal Hospital for Neuro-disability , West Hill, Putney, London SW15 3SW, UK
1 shared publicationC. Bowen
The Institute for Neuropalliative Rehabilitation, Royal Hospital for Neuro-disability, London SW153SW, UK
1 shared publication
Latest Publications
- 18 February 2010
- Published by Taylor & Francis in Psychology & Health
- Vol. 26 (1) , 113-127
Advanced multiple sclerosis and the psychosocial impact on families
This study explores family relationships and support needs when adapting to a relative's advanced-multiple sclerosis (MS) around transition into care. A multi-site qualitative study of relatives of people with advanced-MS was conducted. A purposive sample of 25 relatives was selected and interviewed either in the care home or participants’ homes. Interviews were recorded, transcribed and analysed using grounded theory methodology and Atlas.ti 5.2 software. Data quality enhancement involved: a self-report questionnaire; triangulation and member-checking. Themes derived from the data were: information, communication and understanding; family relationships, roles and responsibilities; emotions, coping and support; life outlook and reflection. Provision of information and support for families around the transition into care appears to be inconsistent despite there being a need for family members to ask questions and discuss the impact of the condition. Relatives reported that as a family and as individuals they faced significant challenges and were in great need of support at times, but reflected that they would have found it very difficult to accept. Relatives were also often unsure what type of support would have helped. For care providers, there needs to be a shift from the traditional health care professional ‘patient-centred’ mindset towards more proactive family-centred approaches and steps to encourage this are articulated.
- 18 February 2010
- Published by Taylor & Francis in Psychology & Health
- Vol. 26 (1) , 113-127
Advanced multiple sclerosis and the psychosocial impact on families
This study explores family relationships and support needs when adapting to a relative's advanced-multiple sclerosis (MS) around transition into care. A multi-site qualitative study of relatives of people with advanced-MS was conducted. A purposive sample of 25 relatives was selected and interviewed either in the care home or participants’ homes. Interviews were recorded, transcribed and analysed using grounded theory methodology and Atlas.ti 5.2 software. Data quality enhancement involved: a self-report questionnaire; triangulation and member-checking. Themes derived from the data were: information, communication and understanding; family relationships, roles and responsibilities; emotions, coping and support; life outlook and reflection. Provision of information and support for families around the transition into care appears to be inconsistent despite there being a need for family members to ask questions and discuss the impact of the condition. Relatives reported that as a family and as individuals they faced significant challenges and were in great need of support at times, but reflected that they would have found it very difficult to accept. Relatives were also often unsure what type of support would have helped. For care providers, there needs to be a shift from the traditional health care professional ‘patient-centred’ mindset towards more proactive family-centred approaches and steps to encourage this are articulated.
- 11 January 2005
- Published by Taylor & Francis in Neuropsychological Rehabilitation
- Vol. 15 (3-4) , 184-189
Incidence and prevalence of the vegetative and minimally conscious states
The methodological difficulties of obtaining accurate epidemiological data for vegetative state (VS) and minimally conscious state (MCS) are considered, and prompt the conclusion that published data are of uncertain validity, partly due to variation in the criteria for diagnosis. On the basis of these data, incidence of VS continuing for at least six months arises at a rate of between 5 and 25 per million population (PMP). The prevalence of VS in adults in the US is between 40 and 168 PMP, and may be lower in the UK, but precise figures are not available. The incidence and prevalence of MCS have yet to be established.
- 11 January 2005
- Published by Taylor & Francis in Neuropsychological Rehabilitation
- Vol. 15 (3-4) , 184-189
Incidence and prevalence of the vegetative and minimally conscious states
The methodological difficulties of obtaining accurate epidemiological data for vegetative state (VS) and minimally conscious state (MCS) are considered, and prompt the conclusion that published data are of uncertain validity, partly due to variation in the criteria for diagnosis. On the basis of these data, incidence of VS continuing for at least six months arises at a rate of between 5 and 25 per million population (PMP). The prevalence of VS in adults in the US is between 40 and 168 PMP, and may be lower in the UK, but precise figures are not available. The incidence and prevalence of MCS have yet to be established.
- 24 August 2004
- Published by Cambridge University Press (CUP) in Ageing and Society
- Vol. 24 (5) , 755-769
Quality of life perceptions and social comparisons in healthy old age
This paper reports a study of the influence of healthy older people's type of residence and social comparison strategies on their quality of life perceptions. Data were collected from 190 participants aged 65 or more years resident in one London Borough. Participants were classified by their type of residence, and their quality of life was assessed by the Schedule for Evaluation of Individual Quality of Life: Direct Weighting (SEIQoL-DW). Among the reported social comparison judgements, the dominant strategy was ‘Downward Contrast’. It was the sole strategy for 78 per cent of those studied, and was significantly associated with a higher perceived quality of life. Among other statistically significant findings, it was found that positive orientation, optimistic orientation, and the use of Contrast rather than Identification comparisons associated with a better reported quality of life. The over-riding influence of Downward Contrast comparisons was also confirmed: this strategy appears to be adaptive and functional in enhancing perceived quality of life. The effect is not mediated by depression, although differences in comparison strategy were observed among groups with different residential status. The possibility of an intervention to enhance the perceived quality of life is discussed.
- 24 August 2004
- Published by Cambridge University Press (CUP) in Ageing and Society
- Vol. 24 (5) , 755-769
Quality of life perceptions and social comparisons in healthy old age
This paper reports a study of the influence of healthy older people's type of residence and social comparison strategies on their quality of life perceptions. Data were collected from 190 participants aged 65 or more years resident in one London Borough. Participants were classified by their type of residence, and their quality of life was assessed by the Schedule for Evaluation of Individual Quality of Life: Direct Weighting (SEIQoL-DW). Among the reported social comparison judgements, the dominant strategy was ‘Downward Contrast’. It was the sole strategy for 78 per cent of those studied, and was significantly associated with a higher perceived quality of life. Among other statistically significant findings, it was found that positive orientation, optimistic orientation, and the use of Contrast rather than Identification comparisons associated with a better reported quality of life. The over-riding influence of Downward Contrast comparisons was also confirmed: this strategy appears to be adaptive and functional in enhancing perceived quality of life. The effect is not mediated by depression, although differences in comparison strategy were observed among groups with different residential status. The possibility of an intervention to enhance the perceived quality of life is discussed.
- Open Access
- 1 April 2004
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 75 (4) , 526-527
The MS symptom and impact diary (MSSID): psychometric evaluation of a new instrument to measure the day to day impact of multiple sclerosis
This study aimed to develop further a diary originally devised to measure the impact of multiple sclerosis (MS) as part of a cost utility study of beta interferon, and to evaluate its reliability, validity, and responsiveness in an outpatient sample of people with MS.The original diary was further developed using qualitative and quantitative methods to ensure that it addressed the views of people with MS. The psychometric properties of the MS Symptom and Impact Diary (MSSID) were evaluated in a sample of 77 people who completed the MSSID daily for 12 weeks. Internal and test-retest reliability, discriminant and convergent validity, and responsiveness were assessed using traditional psychometric methods.The MSSID formed three, internally consistent scales that measured mobility, fatigue, and the overall impact of MS. The test-retest reliability of the mobility scale was adequate for individual comparisons (ICC>0.90) and the fatigue and overall impact scales were adequate for group comparisons (ICC>0.70). The MSSID was able to distinguish between clinical groups depending on clinical course, indoor ambulation status, and relapse status. It demonstrated associations with other single point instruments in the expected direction. Compared with single point instruments, its responsiveness was similar or better, especially in detecting short term improvements in functioning.The MSSID may provide a useful complement to currently available instruments to measure the outcomes of MS within clinical trials. Further research is needed to explore its feasibility in the context of a randomised controlled trial and its utility for clinicians.
- 1 April 2004
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 75 (4) , 526-527
Open AccessThe MS symptom and impact diary (MSSID): psychometric evaluation of a new instrument to measure the day to day impact of multiple sclerosis
This study aimed to develop further a diary originally devised to measure the impact of multiple sclerosis (MS) as part of a cost utility study of beta interferon, and to evaluate its reliability, validity, and responsiveness in an outpatient sample of people with MS.The original diary was further developed using qualitative and quantitative methods to ensure that it addressed the views of people with MS. The psychometric properties of the MS Symptom and Impact Diary (MSSID) were evaluated in a sample of 77 people who completed the MSSID daily for 12 weeks. Internal and test-retest reliability, discriminant and convergent validity, and responsiveness were assessed using traditional psychometric methods.The MSSID formed three, internally consistent scales that measured mobility, fatigue, and the overall impact of MS. The test-retest reliability of the mobility scale was adequate for individual comparisons (ICC>0.90) and the fatigue and overall impact scales were adequate for group comparisons (ICC>0.70). The MSSID was able to distinguish between clinical groups depending on clinical course, indoor ambulation status, and relapse status. It demonstrated associations with other single point instruments in the expected direction. Compared with single point instruments, its responsiveness was similar or better, especially in detecting short term improvements in functioning.The MSSID may provide a useful complement to currently available instruments to measure the outcomes of MS within clinical trials. Further research is needed to explore its feasibility in the context of a randomised controlled trial and its utility for clinicians.